Suchergebnisse - "Petrelli, Annalisa"

PubPharm (40)

1

Genome editing of a recalcitrant wine grape genotype by lipofectamine-mediated delivery of CRISPR/Cas9 ribonucleoproteins to protoplasts

enthalten in: The Plant journal : for cell and molecular biology | 2024

von Gambino, G. | Nuzzo, F. | Moine, A. | +8

2

BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

enthalten in: Cancer research | 2023

von Petrelli, A. | Rizzolio, S. | Pietrantonio, F. | +30

3

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients

enthalten in: Cells | 2022

von Berrino, E. | Miglio, U. | Bellomo, S. | +9

4

Personalized therapeutic strategies in HER2-driven gastric cancer

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2021

von Ughetto, S. | Migliore, C. | Pietrantonio, F. | +40

5

Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Corso, S. | Pietrantonio, F. | Apicella, M. | +39

CommentIn: Clin Cancer Res. 2021 Jun 1;27(11):2964-2966. - PMID 33771852

6

Personalized therapeutic strategies in HER2-driven gastric cancer

enthalten in: Gastric cancer | 2021

von Ughetto, S. | Migliore, C. | Pietrantonio, F. | +40

7

Personalized therapeutic strategies in HER2-driven gastric cancer

enthalten in: Gastric cancer | 2021

von Ughetto, S. | Migliore, C. | Pietrantonio, F. | +40

8

Personalized therapeutic strategies in HER2-driven gastric cancer

enthalten in: Gastric Cancer | 2021

von Ughetto, S. | Migliore, C. | Pietrantonio, F. | +40

9

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

enthalten in: ESMO open | 2020

von Petrelli, A. | Bellomo, S. | Sarotto, I. | +17

10

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

enthalten in: Journal of hepatology | 2020

von Kowalik, M. | Puliga, E. | Cabras, L. | +17